California Nanotechnologies Corp
XTSX:CNO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.28
1.04
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
CNO
stock under the Base Case scenario is
0.42
CAD.
Compared to the current market price of 0.37 CAD,
California Nanotechnologies Corp
is
Undervalued by 12%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for California Nanotechnologies Corp.
| ZA |
S
|
Sanlam Ltd
JSE:SLM
|
|
| CN |
|
China Life Insurance Co Ltd
SSE:601628
|
|
| CN |
|
Ping An Insurance Group Co of China Ltd
SSE:601318
|
|
| ZA |
D
|
Discovery Ltd
JSE:DSY
|
|
| HK |
|
AIA Group Ltd
HKEX:1299
|
|
| ZA |
O
|
OUTsurance Group Ltd
JSE:OUT
|
|
| ZA |
O
|
Old Mutual Ltd
JSE:OMU
|
|
| CA |
|
Manulife Financial Corp
TSX:MFC
|
|
| IN |
|
Life Insurance Corporation Of India
NSE:LICI
|
|
| US |
|
Aflac Inc
NYSE:AFL
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
California Nanotechnologies Corp
Balance Sheet Decomposition
California Nanotechnologies Corp
| Current Assets | 995.7k |
| Cash & Short-Term Investments | 238.2k |
| Receivables | 689.7k |
| Other Current Assets | 67.8k |
| Non-Current Assets | 3.4m |
| PP&E | 3.3m |
| Intangibles | 2.8k |
| Other Non-Current Assets | 41.7k |
| Current Liabilities | 834k |
| Accounts Payable | 365.9k |
| Other Current Liabilities | 468.1k |
| Non-Current Liabilities | 1.2m |
| Long-Term Debt | 1.2m |
Free Cash Flow Analysis
California Nanotechnologies Corp
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
California Nanotechnologies Corp
|
Revenue
|
4.5m
USD
|
|
Cost of Revenue
|
-1.4m
USD
|
|
Gross Profit
|
3.1m
USD
|
|
Operating Expenses
|
-3.6m
USD
|
|
Operating Income
|
-570.6k
USD
|
|
Other Expenses
|
-369k
USD
|
|
Net Income
|
-939.6k
USD
|
CNO Profitability Score
Profitability Due Diligence
California Nanotechnologies Corp's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
Score
California Nanotechnologies Corp's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
CNO Solvency Score
Solvency Due Diligence
California Nanotechnologies Corp's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Score
California Nanotechnologies Corp's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CNO Price Targets Summary
California Nanotechnologies Corp
Dividends
Current shareholder yield for
CNO is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CNO
stock under the Base Case scenario is
0.42
CAD.
Compared to the current market price of 0.37 CAD,
California Nanotechnologies Corp
is
Undervalued by 12%.